Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort. - Wikidata - wikimedia - TriplyDB

Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.

Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.

http://www.wikidata.org/entity/Q37713060

about

Prevalence and factors associated with chronic kidney disease and end-stage renal disease in HIV-1-infected Asian patients in Tokyo.Potential kidney toxicity from the antiviral drug tenofovir: new indications, new formulations, and a new prodrug.

P2860

Q47151132-DAFB9F01-CBF5-4ECE-9F01-DA4ECACA28B6 Q47560453-B00A3117-204D-4FC6-9CBB-CE3A8BB02D95

P2860

Effect of Tenofovir Disoproxil Fumarate on Incidence of Chronic Kidney Disease and Rate of Estimated Glomerular Filtration Rate Decrement in HIV-1-Infected Treatment-Naïve Asian Patients: Results from 12-Year Observational Cohort.

http://www.wikidata.org/entity/Q37713060

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Effect of Tenofovir Disoproxil ...... 12-Year Observational Cohort.

@en

Effect of Tenofovir Disoproxil ...... 12-Year Observational Cohort.

@nl

type

label

Effect of Tenofovir Disoproxil ...... 12-Year Observational Cohort.

@en

Effect of Tenofovir Disoproxil ...... 12-Year Observational Cohort.

@nl

prefLabel

Effect of Tenofovir Disoproxil ...... 12-Year Observational Cohort.

@en

Effect of Tenofovir Disoproxil ...... 12-Year Observational Cohort.

@nl

P1433

Q37713060-91DEF1C4-C609-4DF4-B145-C78440CB46BC

P1476

Q37713060-00EAC486-5208-491C-8175-48C77AB55CBF

P2093

Q37713060-0072E20F-0084-402A-9415-80047C73E515

Q37713060-3B152961-EF7A-49E7-99B5-6F3C0D6CE29B

Q37713060-3F381343-8511-47B6-94A2-91BAA7A357DF

Q37713060-42B80421-955C-483E-844D-EE4BF02EF7C1

Q37713060-63B65C05-CBCE-4AFC-AB9D-0090DEF3B9F0

Q37713060-86A1AC69-A22C-4CCF-8530-14912A1CF5FA

Q37713060-D5DCBA47-873C-4808-A82C-5568E35B4D36

P2860

Q37713060-1351FBAB-CBFA-4D56-BEEA-92B891324A67

Q37713060-1896C9A6-4659-4646-A2F4-7D1B5DCE2A6D

Q37713060-1D928AC6-0F26-468A-83FD-4BAF57C1B16E

Q37713060-234CC2D9-C678-4AAC-977F-2BB1D791F3BE

Q37713060-2C925DDB-33B5-48FA-AF40-F095CAFEED07

Q37713060-40450D3B-1455-4604-8DD7-B06C1210BDE0

Q37713060-40C77ED1-49DC-4194-9AC9-10FDEF91EACB

Q37713060-42B66874-4957-4A89-8B4F-A6E9F1BB5E3A

Q37713060-4345D396-2330-4CEA-BDD9-223CE83117F8

Q37713060-457CE82A-A460-4A9E-B8ED-AB3ABB012749

P304

Q37713060-6859CA52-E334-42DF-B872-29F2D47BFAF2

P31

Q37713060-CCAA4D8F-22AA-468E-92F3-51F760E6E651

P356

Q37713060-CBAC4EE8-821C-4CBC-B7E0-F78344FC724B

P433

Q37713060-37B26DA1-96B4-4897-8929-A470BFB999AE

P478

Q37713060-BDF5A83F-654A-4DB3-9C8C-B4206FF031BC

P50

Q37713060-8EF0A847-602D-4AD6-A911-F257BC20ED8F

P577

Q37713060-7DB0A2B5-4E4A-4F69-9AD9-E49FA4B3BFBD

P698

Q37713060-E7016824-F699-467C-BEB8-66191202B634

P932

Q37713060-60EAF821-EB08-4B1A-871D-7CDB4B66510F

P356

P1433

AIDS Patient Care and Stds

P1476

Effect of Tenofovir Disoproxil ...... m 12-Year Observational Cohort

@en

P2093

Hiroyuki Gatanaga

http://www.w3.org/2001/XMLSchema#string

Shinichi Oka

http://www.w3.org/2001/XMLSchema#string

Soichiro Suzuki

http://www.w3.org/2001/XMLSchema#string

Takeshi Nishijima

http://www.w3.org/2001/XMLSchema#string

Takuma Kurosawa

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Mutoh

http://www.w3.org/2001/XMLSchema#string

Yoshimi Kikuchi

http://www.w3.org/2001/XMLSchema#string

P2860

A new equation to estimate glomerular filtration rate

Role of traditional risk factors and antiretroviral drugs in the incidence of chronic kidney disease, ANRS CO3 Aquitaine cohort, France, 2004-2012

Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapy.

Renal function declines more in tenofovir- than abacavir-based antiretroviral therapy in low-body weight treatment-naïve patients with HIV infection.

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.

WHO antiretroviral therapy guidelines 2010 and impact of tenofovir on chronic kidney disease in Vietnamese HIV-infected patients.

Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India

End-stage renal disease among HIV-infected adults in North America.

P304

105-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/APC.2016.0286

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28282247

http://www.w3.org/2001/XMLSchema#string

P932

5359640

http://www.w3.org/2001/XMLSchema#string